Evidence map›Paper›PMID 32238433›Full record

ArticleJournal of clinical microbiology2020

Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing

Christian M Gill, Maxwell J Lasko, Tomefa E Asempa, David P Nicolau

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  13. Molecular epidemiology of multidrug-resistantFrontiers in cellular and infection microbiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Evaluation of phenotypic detection of carbapenemase-producing Pseudomonas spp. from clinical isolates.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Christian M GillCenter for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
Maxwell J LaskoCenter for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
Tomefa E AsempaCenter for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
David P NicolauCenter for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA david.nicolau@hhchealth.org.
Hartford Financial Services (United States)Hartford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of carbapenem-resistant

Indexed as

beta-LactamasesPseudomonas aeruginosaAnti-Bacterial AgentsBacterial ProteinsBrazilCarbapenemsEdetic AcidHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsEdetic Acidbeta-lactamasescarbapenemasemetallo-beta-lactamasesPseudomonas aeruginosa

Identifiers

PMID32238433
PMCPMC7269398
OpenAlexW3014918727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.